Vitalia24 - Merkez Prime Hospital

Vitalia24 - Merkez Prime Hospital - Overview

We are thrilled to have you at our unique medical facility.

Our team of experts is committed to offering top-notch care in stem cell and exo some therapies.

Our goal is to deliver advanced treatments to individuals looking for new approaches to difficult health issues, with a special emphasis on autism, neurodegenerative diseases,and chronic illnesses.

Technological Innovations

Our treatment facility consistently invests in cutting-edge medical technologies to improve the accuracy of diagnoses and the effectiveness of treatments. This encompassesstate-of-the-art imaging technologies like MRI, CT scans, and digital X-rays,alongside fully equipped laboratory facilities for comprehensive testing and analysis. The adoption of electronic health records (EHR) facilitates smooth coordination of patient care across all departments.

Treatment Location - Merkez Prime Hospital

The hospital is situated in Gebze, near Istanbul, Turkey, and is renowned for its top-notch medical care and modern amenities. Its location in Gebze, a major industrial center in the Kocaeli Province, allows it to serve a large number of people in the area.

Merkez Prime Hospital offers state-of-the-art infrastructure and advanced medical technology, ensuring patients receive top-quality care. The hospital includes various specialized departments, such as cardiology, orthopedics, neurology,oncology, and pediatrics. Each department is equipped with cutting-edge diagnostic and treatment tools, facilitating precise and effective medical interventions.

Centers of Excellence

Autism

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition marked by differences in social communication and the presence of repetitive behaviors or restricted interests. The term "spectrum" acknowledges the broad range of challenges and strengths exhibited by individuals with autism. 

Using Stem Cells and Exosomes for Treating Autism Spectrum Disorder (ASD)

Clinical trials exploring the application of stem cells and their exosomes for autism treatment are rooted in their ability to target fundamental biological abnormalities linked to Autism Spectrum Disorder (ASD). 

Goal

The primary aim of employing stem cells and exosomes for treating ASD is to enhance cognitive function, behavior, and overall quality of life by targeting the fundamental biological abnormalities linked to the disorder.

Neuroprotection and Regeneration

Mesenchymal stem cells (MSCs) have the capacity to differentiate into various cell types, potentially repairing or replacing damaged neurons. They also secrete factors that promote neural cell survival and neurogenesis (the formation of new neurons)..

Anti-inflammatory Properties

Stem cells possess the ability to reduce neuroinflammation, which is thought to be a significant factor in autism pathology. By modulating the immune response, they create a more supportive environment for neural development and function.

Intercellular Communication

Exosomes, small vesicles derived from stem cells, transport proteins, lipids, and RNA, facilitating direct communication between cells. They can deliver therapeutic molecules to specific brain regions.

Immune System Modulation

Exosomes have demonstrated the capability to modulate immune responses, decreasing harmful inflammation and potentially enhancing neurodevelopmental outcomes. Experimental therapies for treating Autism Spectrum Disorder (ASD) involve regenerative medicine techniques aimed at addressing the neurological and developmental challenges associated with autism.

Multiple Sclerosis

Treatment for Multiple Sclerosis (MS) has advanced significantly with the introduction of stem cell therapy and exosome therapy, providing promising prospects for enhanced effectiveness and regenerative solutions.

Using Stem Cells and Exosomes in the Treatment of Multiple Sclerosis (MS)

Stem cell therapy for MS primarily involves the use of hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs). HSCs, derived from bone marrow or blood, can rebuild the immune system to reduce the autoimmune attack on myelin, the protective sheath around nerves. This approach, known as autologous hematopoietic stem cell transplantation (aHSCT), aims to “reset” the immune system. MSCs, on the other hand, have immunomodulatory properties that help reduce inflammation and promote repair.

These cells can differentiate into neural cells, potentially aiding in the regeneration of damaged myelin and neural tissues. Clinical trials have demonstrated that stem cell therapy can significantly reduce disease progression and improve neurological function in MS patients. However, challenges such as ensuring the safety and long-term efficacy of these treatments remain.

Exosome therapy utilizes exosomes, which are nano-sized vesicles secreted by cells, including stem cells. Exosomes contain bioactive molecules like proteins, lipids, and RNA, which can modulate immune responses and promote tissue repair. In MS, exosomes derived from MSCs have shown promise in reducing inflammation, protecting neural cells from damage, and facilitating myelin repair. Exosome therapy offers several advantages, including lower risks of immune rejection and simpler administration compared to whole-cell transplantation. They can cross the blood-brain barrier, making them particularly effective in targeting central nervous system disorders like MS.

Combining stem cell and exosome therapies could synergistically enhance treatment outcomes by providing both cellular and molecular mechanisms for immune modulation and neural repair. While still in the experimental stage, these therapies hold great potential for transforming MS treatment, offering patients the possibility of improved function and quality of life.

Stroke

Recent advancements in stroke treatment have shown promise with the integration of stem cell therapy and exosome therapy. These innovative strategies seek to overcome the constraints of traditional treatments, which primarily concentrate on preventing additional damage and symptom management rather than brain repair.

Diabetes

Recent advancements in diabetes treatment have brought to light the significant potential of both stem cell therapy and exosome therapy. These innovative approaches not only focus on regeneration but also hold promise for offering potentially curative solutions to diabetes.

Process and Services for International Patients

Pre-Treatment Preparation and Consultation

Once all medical records are submitted and our Head Doctor determines the patient's eligibility for treatment, we schedule a Zoom call to provide the family with a comprehensive overview of the proposed treatment. This call offers the family an opportunity to ask any questions they may have.

Dedicated Care Team

Our core team comprises highly skilled and compassionate physicians who are leaders in regenerative medicine. Dr. Alex, our Senior Medical Advisor, brings over 15 years of experience in stem cell research and application, holding a PhD in Biomedical Science with numerous peer-reviewed publications on stem cell therapy's effectiveness and safety. He collaborates with a team of experts with a decade of experience in applying exosome treatments for neurodevelopmental disorders. Dr. Alex's contributions have significantly advanced our understanding of how exosomes can promote neural repair and regeneration.

Community Engagement and Education

We prioritize education and community involvement. Our practice regularly hosts seminars and workshops to educate patients and healthcare professionals on the latest developments in stem cell and exosome therapies. By building an informed community, we empower patients to make well-informed decisions about their healthcare.